Home
Conditions
Subcutaneous Emphysema

Clinical trial condition

Subcutaneous Emphysema

Explore clinical trials studying Subcutaneous Emphysema. Study availability and eligibility vary by location and protocol.

97 public trials 17 recruiting studies

Refine in advanced search Browse all conditions

Subcutaneous Emphysema trial results

Not Yet Recruiting

IBS-Oriented CDED Versus Low FODMAP Diet for Irritable Bowel Syndrome

NCT07707635

Conditions: Colonic Diseases, Colonic Diseases, Functional, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Natural Course and Molecular Basis of Alpha 1- Antitrypsin Deficiency-associated Liver Disease.

NCT07639996

Conditions: Alpha 1-antitrypsin Deficiency (AATD), Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Phase 4, Double-blind Study Evaluating the Response on Computed Tomography (CT) Lung Density Decline Rates of Respreeza / Zemaira Weekly for 3 Years in Adults With alpha1 Antitrypsin Deficiency (AATD)

NCT07326592

Conditions: Alpha1 Antitrypsin Deficiency, Alpha1-Proteinase Inhibitor Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Prevalence of Alpha-1 Antitrypsin Deficiency in Non-Cirrhotic Liver Cancer

NCT07145385

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Emphysema, +9 more
Locations: CHU Bordeaux Bordeaux, France

View Trial Details

Not Yet Recruiting

Permian Health Women's Lung Health Study

NCT06029543

Conditions: Alpha 1-Antitrypsin, COPD, Chronic Disease, +17 more
Locations: Gamcotrap Kanifing, The Gambia

View Trial Details

Completed

A Phase 1 Research Study to Evaluate Safety, Tolerability, and Pharmacokinetics of WVE-006 in Healthy Participants With Wild-type AAT Expression (RestorAATion-1)

NCT06186492

Conditions: Alpha-1 Antitrypsin Deficiency (AATD), Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
Locations: Simbec-Orion Clinical Pharmacology, Merthyr Tydfil, Wales, United Kingdom

View Trial Details

Completed

Study of ARO-AAT in Normal Adult Volunteers

NCT03362242

Conditions: Alpha 1-Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
Locations: Research Site 1 Grafton, Auckland, New Zealand

View Trial Details

Completed

Effect Of Pulmonary Rehabilitation in Patients With Alpha-1 Antitrypsin Deficiency

NCT07242079

Conditions: Alpha-1 Antitrypsin Deficiency (AATD), Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
Locations: University of Parma Parma, Italy

View Trial Details

Completed

Safety, Tolerability and Pharmacodynamic Effect of Fazirsiran (TAK-999, ARO-AAT)

NCT03945292

Conditions: Alpha 1-Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
Locations: Research Site 5 Birmingham, Alabama, United States

Research Site 9 Phoenix, Arizona, United States

Research Site 14 La Jolla, California, United States

Research Site 17 Los Angeles, California, United States

View all 21 locations

View Trial Details

Completed

Study of Fazirsiran (TAK-999, ARO-AAT) in Patients With Alpha-1 Antitrypsin Deficiency Associated Liver Disease (AATD)

NCT03946449

Conditions: Alpha 1-Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
Locations: Research Center 1 Vienna, Austria

Research Center 1 Aachen, Germany

Research Center 3 Cambridge, United Kingdom

Research Center 2 Edinburgh, United Kingdom

View Trial Details

Subcutaneous Emphysema

Subcutaneous Emphysema trial results

Related conditions